Drug profile · INN
alipogene tiparvovec
GLYBERA
alipogene tiparvovec (GLYBERA) is a triglyceride hydrolytic enzyme.
EMA: unknown Cardiovascular system (C10) C10AX10
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — alipogene tiparvovec
- Class
- Cardiovascular system (C10)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
alipogene tiparvovec (GLYBERA) is a triglyceride hydrolytic enzyme.
Key facts
INN alipogene tiparvovec
Brand GLYBERA
Mechanism Triglyceride hydrolytic enzyme
Target Triglyceride
Therapeutic class Cardiovascular system (C10)
ATC code C10AX10
Mechanism of action
Triglyceride hydrolytic enzyme
Primary target: Triglyceride
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | unknown | — |
Related & competitor drugs
Frequently asked questions
What is alipogene tiparvovec?
alipogene tiparvovec (GLYBERA) is a triglyceride hydrolytic enzyme.
What is the brand name for alipogene tiparvovec?
GLYBERA is a marketed brand name for alipogene tiparvovec. Check FDA Drugs@FDA for the current US label holder and prescribing information.